‘Enforcement 40’ for 2020
Join Us On LinkedIn
Join the Securities Litigation and Enforcement Group on LinkedIn
You are browsing the site archives by date.
By Securities Docket on September 4, 2013, 1:51 pm
A Chinese police investigation into drugmaker GlaxoSmithKline has discovered that alleged bribery of doctors in China was coordinated by the British company and was not the work of individual employees, state media reported on Tuesday. via Bribery by GSK China was coordinated at company level: Xinhua — Reuters
By Securities Docket on September 4, 2013, 1:44 pm
…. We have recently completed, and intend to maintain, a database of SEC enforcement practices, and in this post, we shed some factual light on what the SEC actually does with respect to prosecuting and penalizing individual and corporate defendants. Specifically, we answer three questions: First, who does the SEC name as defendants—high level executives, […]
By Securities Docket on September 4, 2013, 12:03 pm
Following the suicide of its CFO, Zurich Insurance’s board of directors has opened an investigation into “whether there was undue pressure placed on our CFO.” The CFO’s suicide note blamed the company’s former chairman for creating an unbearable, pressure-packed working environment. via Zurich Investigating Whether ‘Undue Pressure’ on CFO Led to Suicide – Compliance Week
By Securities Docket on September 4, 2013, 8:30 am
Get caught up with the Securities Docket News Wire for September 3, 2013.
By Securities Docket on September 4, 2013, 7:34 am
Britain‘s fraud agency will prosecute Olympus Corp. and its British unit Gyrus for falsifying accounts, the Japanese medical equipment maker said on Wednesday, dragging a $1.7 billion (1.08 billion pounds) accounting scandal back into the spotlight after it erupted nearly two years ago…. The move by the Serious Fraud Office (SFO) revives the scandal after […]